Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Juxtarenal Abdominal Aortic Aneurysm

NCT07441564 | Not Yet Recruiting

• 2 other identifiers: 2023/0298/HP2024-A01808-39
• Study Type: interventional
• Target: 206
• Locations: 1 country
• Sites: 7

Brief Summary

Juxta-renal abdominal aortic aneurysms (AAA) are challenging to treat with standard endovascular techniques (EVAR) due to their proximity to the renal arteries. Open surgical repair continues to be used in patients unsuitable for EVAR but carries a high risk of acute kidney injury (AKI), up to 24%. Postoperative AKI is a strong predictor of both short- and long-term cardiovascular mortality. The KDIGO criteria are used to better define and stage AKI. Pharmacological prevention strategies have shown limited effectiveness, prompting interest in ischemic preconditioning (IPC). Remote IPC has shown mixed results in cardiac and vascular surgery, depending on patient risk and protocols used. Local IPC, applied directly near the renal arteries, has shown promising renal protection in animal models. However, this technique has never been clinically tested in humans. We propose here a randomized trial to assess the efficacy of local IPC before suprarenal aortic clamping during open repair of juxta-renal AAA to reduce postoperative AKI.

Conditions

Aneurysm Aortic

Outcome Measures

Primary Outcomes (1)

• To demonstrate the efficacy of ischemic preconditioning (IPC) applied closely to the supra-renal aorta with respect to the occurrence of Acute Kidney Injury (AKI) among patients undergoing open juxtarenal aortic aneurysm surgery.

  The primary endpoint is the occurrence of a postoperative AKI of stage \> 1 before the morning visit on day 8. We use the KDIGO work group's definition of AKI.

  Day 8

Study Arms (2)

Arm 1 - Experimental group:

EXPERIMENTAL

patients with aortic clamping with preconditioning

Procedure: patients with aortic clamping with preconditioning

Arm 2 - Control group:

OTHER

patients with aortic clamping without preconditioning

Procedure: patients with aortic clamping without preconditioning

Interventions

patients with aortic clamping with preconditioning PROCEDURE

Experimental group (arm 1) consists of patients receiving open juxtarenal aortic aneurysm surgery with direct preconditioning by clamping the suprarenal aorta, which starts after randomization. The procedure for IPC will be achieved by two cycles of supra-renal aortic cross clamping during 5 minutes followed by an unclamping period of 5 minutes before starting the supra-renal aortic cross clamping needed to perform surgery. The level of aortic cross clamping used for IPC will be that required for aortic repair.

Arm 1 - Experimental group:

patients with aortic clamping without preconditioning PROCEDURE

Control group (arm 2) consists of patients receiving open juxtarenal aortic aneurysm surgery without preconditionning

Arm 2 - Control group:

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients aged 18-85 years
• Patients with juxtarenal abdominal aortic aneurysms scheduled for open surgery
• Patients with juxtarenal abdominal aortic aneurysms, which require suprarenal aortic cross clamping
• Patients with juxtarenal abdominal aortic aneurysms, which are of atheromatous etiology or which developed after aortic dissection
• Affiliation with, or beneficiary of a Social security (national health insurance) scheme
• Adult having read and understood the information letter and signed the consent form
• Women surgically sterile (absence of ovaries and/or uterus or tubal ligation)

You may not qualify if:

• Patients dependent from dialysis
• Patients with aortic aneurysms, which require reconstruction of the visceral arteries
• Patients with aortic aneurysms, which require supra-visceral aortic cross clamping
• Patients with wall thrombus or calcification of inter- and suprarenal aorta
• Patients with septic aortitis
• Patients with aneurysm requiring stent graft (EVAR) explantation
• Patients requiring emergency surgery
• Patients receiving treatments that may interact with preconditioning: Nicorandil and Glibenclamide
• Pregnant or parturient or breastfeeding woman or absence of proven contraception
• Person deprived of liberty by an administrative or judiciary decision or person placed under judicial protection, under guardianship or curatorship
• Person participating to another trial during the month before randomization
• Medical history or psychological or sensorial abnormality prone to inhibit the subject to understand the conditions required for his/her participation to the protocol or unable to give an informed consent

Sponsors & Collaborators

• University Hospital, Rouen: lead

Study Sites (7)

CHU de DIJON

Dijon, 21000, France

Location

CHU de LILLE

Lille, 59000, France

Location

CHU de NANCY

Nancy, 54511, France

Location

CHU de NANTES

Nantes, 44093, France

Location

Ap-Hp La Pitie

Paris, 75013, France

Location

CHU de ROUEN

Rouen, 76031, France

Location

CHU de TOULOUSE

Toulouse, 31400, France

Location

MeSH Terms

Conditions

Aortic Aneurysm

Condition Hierarchy (Ancestors)

Aneurysm; Vascular Diseases; Cardiovascular Diseases; Aortic Diseases

Central Study Contacts

Didier PLISSONNIER, MD, PHD

CONTACT

02 32 88 66 31; didier.plissonnier@chu-rouen.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Prognostic, prospective, comparative, randomized, open, multi-centre, national study

Study Record Dates

• First Submitted: February 13, 2026
• First Posted: March 2, 2026
• Study Start (Estimated): September 1, 2026
• Primary Completion (Estimated): December 1, 2029
• Study Completion (Estimated): December 1, 2029
• Last Updated: June 9, 2026

Record last verified: 2026-02

Locations

FR (7)